Azora Therapeutics
October 16, 2023
Franciscan B
Gastrointestinal
Azora Therapeutics is a clinical-stage biotechnology company developing potential first-in-class/best-in-class aryl hydrocarbon receptor (AhR) agonists for ulcerative colitis and inflammatory skin diseases.
Speaker(s)
Matt Davidson, PhD
Headquarters Location
Los Angeles, California
Innovation Supporter
SPARK at Stanford
Website
https://www.azoratherapeutics.com/
)
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)